San Francisco, CA – Chronic pain sufferers may find relief with a new, safe and effective non-narcotic treatment solution released by medical device maker DyAnsys, Inc. The company announced today that the four-piece system will be available in select doctors’ offices and pain management centers.
“This is a breakthrough alternative for patients who have not been able to find relief from long-term pain,” said DyAnsys CEO Srini Nageshwar. “Pain, especially pain that has no discernable cause, can interfere with all aspects of a person’s life. This provides a comprehensive, non-narcotic treatment solution.”
The core of the treatment solution is Primary Relief®, a small device worn behind the ear to administer continuous pulses of low-level electrical current to nerve endings in the ear. These pulses travel through the nerve tracks into the central lobe of the brain causing the release of endorphins, the body’s natural opiates. These opiates travel through the bloodstream and inhibit pain throughout the body. The reduction of pain increases circulation and causes relaxation. The Primary Relief was cleared by the Food & Drug Administration for sale in the US.
Patients are monitored with a handheld Primary Relief® Ansiscope. Measurements taken with the ANSiScope are automatically captured on the device as an electronic patient record. The patient’s vital signs and other information can be manually added to create an easily transferrable integrated record. The ANSiScope features a built-in display screen with functions that can be viewed on an external monitor.
The placement of the electrodes is determined by the Primary Relief Tester®, used to find the best aural stimulation points based on where the patient has been experiencing pain. The Primary Relief Tester® assures physicians and patients that the Primary Relief device is working correctly before application. The placement of Primary Relief takes about ten minutes. Patients continually wear the light, unobtrusive device for four days while they go about their regular activities. A new Primary Relief is applied every week by the healthcare provider. Total treatment typically takes ten to twelve weeks.
The Primary Relief is the next generation of the company’s effective Point Stimulation Therapy System, which has been in clinical use for several years. In addition to being used to treat chronic pain, Primary Relief can be used for post-operative pain therapy.
“This is an important option for patients who have been struggling with pain, and who either don’t want to take medication or have not responded to it,” said Rick Lambert, M.D., Medical Director of Montvale Health Associates. “The (Primary Relief) is easy for patients to use, and there are no negative effects.”
Patients and health care providers can call the company’s toll-free number (1-888-950-4321) for more information on the non-narcotic pain solution.
DyAnsys Inc. is a global company headquartered in the Silicon Valley (California, USA) with subsidiaries in Switzerland and India. DyAnsys provides advanced medical diagnostic and monitoring systems to clinicians in individual practices and hospitals. DyAnsys and ANSiscope are registered trademarks, and Primary Relief, Primary Relief Locator and Primary Relief Tester are trademarks of DyAnsys, Inc.
